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The morbidity and mortality of respiratory tract infections in Europe throughout history isincalculable, but when the English writer John Bunyan coined the phrase ‘‘Captain of all these
men of death’’ to describe tuberculosis (TB) in 1680, TB was estimated to cause 15–20% of all
deaths in Europe. It was hard to imagine at that time that another infection might one day take
this crown. In 1918, the father of modern medicine, Sir William Osler, observed that pneumonia
had overtaken TB as one of the leading causes of death in Europe and described pneumonia as the
‘‘Captain of the men of death’’, an appellation it still justifies today.
While improvements in public health and sanitation reduced mortality from many, mostly food-
borne, infections, it was not until the widespread introduction of antibiotics after the Second
World War that mortality from pneumonia in Europe began to fall significantly. Since then, there
have been few new treatments and limited progress in reducing mortality from pneumonia. While
mortality rates for cardiovascular diseases and many cancers are falling in Europe, the rates for
hospitalisation and deaths from pneumonia are static or rising. This is a disease of huge clinical
and public health importance.
It is for this reason we are delighted to introduce the 63rd issue of the European Respiratory
Monograph (ERM), dedicated to the epidemiology, pathophysiology, microbiology, investigation,
management and prevention of community-acquired pneumonia (CAP). The 20 chapters of this
ERM serve as a comprehensive text, describing the modern approach to this disease, each chapter
written by internationally recognised experts in their field. Major changes in our understanding
and management of pneumonia have been emphasised, including the new microbiology
techniques that are set to change how we detect and diagnose infection, the emerging role of
anti-inflammatory therapies and the current controversy over inhaled corticosteroids as a cause of
pneumonia in patients with chronic obstructive pulmonary disease. The changing face of
pneumonia reflects the world around us, with an increasing impact of antibiotic resistance and an
ageing population with comorbidities to the fore. We now recognise the important impact of this
disease on long-term outcomes. Previously regarded as a purely ‘‘acute’’ condition, new evidence
shows that pneumonia can destabilise the precarious balance in patients with comorbidities and
poor performance status, even after apparent recovery from the acute episode.
This is a broad and multidisciplinary book, covering diverse specialities from epidemiology to the
basic science of pneumococcal infection, and reviewing CAP in children, in primary care and in
the intensive care unit.
As much as in any other disease, CAP requires improvements in clinical care and to achieve
progress through innovative research. Every clinician in every speciality will encounter pneumonia
in their daily practice and we hope that this ERM will serve as a complete and up-to-date reference
for our colleagues.
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